APA

Haanen J. B. A. G., Baars A., Gomez R., Weder P., Smits M., de Gruijl T. D., von Blomberg B. M. E., Bloemena E., Scheper R. J., van Ham S. M., Pinedo H. M. & van den Eertwegh A. J. M. (20060314). Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients. : Cancer immunology, immunotherapy : CII.

Chicago

Haanen J B A G, Baars A, Gomez R, Weder P, Smits M, de Gruijl T D, von Blomberg B M E, Bloemena E, Scheper R J, van Ham S M, Pinedo H M and van den Eertwegh A J M. 20060314. Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients. : Cancer immunology, immunotherapy : CII.

Harvard

Haanen J. B. A. G., Baars A., Gomez R., Weder P., Smits M., de Gruijl T. D., von Blomberg B. M. E., Bloemena E., Scheper R. J., van Ham S. M., Pinedo H. M. and van den Eertwegh A. J. M. (20060314). Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients. : Cancer immunology, immunotherapy : CII.

MLA

Haanen J B A G, Baars A, Gomez R, Weder P, Smits M, de Gruijl T D, von Blomberg B M E, Bloemena E, Scheper R J, van Ham S M, Pinedo H M and van den Eertwegh A J M. Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients. : Cancer immunology, immunotherapy : CII. 20060314.